ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2017 American Transplant Congress

    Simultaneous or Sequential Heart-Liver Transplantation Confer Superior Survival in Patients with Listed for Heart-Liver Transplantation: A National Analysis.

    K. Anderson,1 M. Mulvihill,2 B. Yerokun,2 A. Barbas,2 M. Hartwig.2

    1Duke School of Medicine, Durham, NC; 2Dept of Surgery, Duke University Medical Center, Durham, NC

    Background: Simultaneous heart-liver transplantation (TXP), for patients with combined heart and liver failure, confers survival benefit over remaining on the waitlist. Whether heart TXP followed…
  • 2017 American Transplant Congress

    Assessment of the Risk Index for Living Donor Kidney Transplantation (LKDPI) in a European Cohort.

    O. Staeck, G. Rehse, D. Khadzhynov, A. Kleinsteuber, L. Lehner, M. Duerr, K. Budde, F. Halleck.

    Nephrology, Charité Universitaetsmedizin, Berlin, Germany

    Introduction: Recently, a risk index for living donor kidney transplantation (LKDPI) was proposed (Massie et al. AJT 2016) to compare living donor kidneys (LDK) to…
  • 2017 American Transplant Congress

    Impact of Antihypertensive (AHT) Choice and Advagraf® Dose on Immunologic Events in Renal Allografts 24 Months Post-Transplantation (Tx).

    D. Rush,1 S. Cockfield,2 S. Wilson,3 J. Howell,4 FKC-014 Study Group.

    1Health Sciences Centre, Winnipeg, MB, Canada; 2University of Alberta Hospital, Edmonton, AB, Canada; 3Astellas Pharma Global Development, Northbrook, IL; 4Astellas Pharma Global Development, Markham, ON, Canada

    Renal allograft inflammation may be modulated by ACEi- or ARB-type AHTs (renin-angiotensin system (RAS)-targeting drugs that may inhibit calcineurin) or by optimizing tacrolimus (TAC) exposure.…
  • 2017 American Transplant Congress

    Pre-Transplant Evaluation of KSORTSM to Assess Risk for Rejection in Highly Sensitized Patients.

    S. Nandoe,1 S. Roedder,3 S. Hsieh,1 T. Sigdel,1 P. Lindner,4 J. Ekberg,4 J. Alberu,5 F. Vincenti,1 M. Sarwal.1

    1UCSF, San Francisco, CA; 2Immucor, Norcross, GA; 3Gothenburg University, Gothenburg, Sweden; 4Salvador Zubiran, Mexico City, Mexico

    Study purpose: To investigate the kSORTSM molecular expression assay for immune risk assessment in renal transplant (tx) recipients prior to tx for correlation of pre-tx…
  • 2017 American Transplant Congress

    Desensitization versus Deceased Donor Kidney Transplantation: What to Choose When Both Become Available?

    B. Orandi,1 X. Luo,2 J. Garonzik-Wang,2 R. Montgomery,3 D. Segev.2

    1UCSF, San Francisco; 2Johns Hopkins, Baltimore; 3NYU, New York

    Kidney allocation system changes have improved deceased donor kidney transplant (DDKT) access for highly sensitized patients. For patients with a willing live donor but requiring…
  • 2017 American Transplant Congress

    Is Deceased Donor Kidney Transplantation (DDTX) Justified in Patients with More Than 10 Years of Pre-TX Dialysis Exposure?

    C. Rose, J. Gill, J. Lesage, Y. Joffres, J. Gill.

    UBC, Vancouver, Canada

    Background: The new kidney allocation system (KAS) led to an increase in DDTX among patients with ≥10 years of pre-TX dialysis exposure. We aimed to…
  • 2017 American Transplant Congress

    Immunosuppression and Graft Rejection in Living-Related HLA-Identical Renal Transplantation.

    R. Ossman,1 M. Jamme,1 P. Galichon,1 A. Hertig,1 B. Moulin,2 C. Legendre,3 E. Morelon,4 J.-L. Taupin,5 L. Rostaing,6 E. Rondeau.1

    1Urgences Néphrologiques et Transplantation, Hôpital Tenon, RADOVFULL Study Group, Université Pierre et Marie Curie, Paris, France; 2Néphrologie et Transplantation, Hôpital Civil, Strasbourg, France; 3Néphrologie et Transplantation, Hôpital Necker-Enfants Malades, Université Paris Descartes, Paris, France; 4Néphrologie et Transplantation, Hôpital Edouard Herriot, Université de Lyon, Lyon, France; 5Laboratoire d'Histocompatibilité, Hôpital Saint-Louis, Université Paris Diderot, Paris, France; 6Néphrologie et Transplantation d'Organes, Université Paul Sabatier, Toulouse, France

    Purpose: We aimed to describe the immunosuppressive regimens and graft rejection rates in living-related HLA-identical (LR HLAid) renal transplantation.Methods: We performed a retrospective multicenter analysis…
  • 2017 American Transplant Congress

    A Low-Dose Anti-Hepatitis B Immunoglobulin Regimen for Prophylaxis of Hepatitis B Recurrence.

    W.-C. Lee, Y.-C. Wang, C.-H. Cheng, T.-H. Wu, C.-F. Lee, T.-J. Wu, H.-S. Chou, K.-M. Chan.

    Liver and Transplantation Surgery, Chang-Gung Memorial Hospital, Taoyuan, Taiwan

    Background: Hepatitis B virus (HBV)-related liver disease is the major indication of liver transplantation in Asian countries. Combination of anti-hepatitis B immunoglobulin (HBIg) and anti-viral…
  • 2017 American Transplant Congress

    Reduced Conversion from IgM Anti-HLA-DSA to IgG Anti-HLA-DSA in Belatacept-Treated vs. Cyclosporine-Treated Patients in BENEFIT and BENEFIT-EXT Trials.

    M. Everly,1 R. Townsend,2 H. Gebel,3 R. Bray.3

    1Terasaki Foundation Laboratory, Los Angeles, CA; 2Bristol-Myers Squibb, Lawrenceville, NJ; 3Emory University, Atlanta, GA

    Post-transplant, up to 50% of recipients develop IgM DSA. Half of these patients go on to develop IgG DSA. Importantly, patients that progress to IgG…
  • 2017 American Transplant Congress

    High CTLA-4 Expression and Diminished FOXO3 Expression Underlie Differential CD28 Signaling on Human Memory Th17 Cells.

    S. Krummey,1 S. Suchard,1 S. Nadler,2 C. Larsen,2 M. Ford.1

    1Emory Transplant Center, Emory University School of Medicine, Atlanta, GA; 2Bristol Meyers Squibb, Princeton, NJ

    Pathogen primed memory T cells can cross-react with allogeneic antigen and mediate graft rejection, a process termed allogeneic heterologous immunity. Th17 cells are pro-inflammatory CD4+…
  • « Previous Page
  • 1
  • …
  • 67
  • 68
  • 69
  • 70
  • 71
  • …
  • 181
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences